2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 7

In this episode, we review recommendations 45 to 50 from the 2025 American Thyroid Association guidelines on long term management of differentiated thyroid cancer. Key topics include:• Individualization of TSH suppression strategy• Long term considerations for TSH suppression in low and intermediate risk patients• Monitoring serum thyroglobulin and Tg antibodies as markers of disease status• Follow up protocols for low risk differentiated thyroid cancer, including when to discontinue ultrasound and biochemical monitoring• The role of radioiodine whole body scintigraphy in follow up care•Indications for advanced imaging with fluorodeoxyglucose PET/CT in high risk patients